Bisphosphonate sequestering agents. Synthesis and preliminary evaluation for in vitro and in vivo uranium(VI) chelation

Eur J Med Chem. 2008 Dec;43(12):2768-77. doi: 10.1016/j.ejmech.2008.01.018. Epub 2008 Jan 30.

Abstract

A library of bisphosphonate-based ligands was prepared using solution-phase parallel synthesis and tested for its uranium-binding properties. With the help of a screening method, based on a chromophoric complex displacement procedure, 23 dipodal and tripodal chelates bearing bisphosphonate chelating functions were found to display very high affinity for the uranyl ion and were selected for evaluation of their in vivo uranyl-removal efficacy. Among them, 11 ligands induced a huge modification of the uranyl biodistribution by deviating the metal from kidney and bones to liver. Among the other ligands, the most potent was the dipodal bisphosphonate 3C which reduced the retention of uranyl and increased its excretion by around 10% of the injected metal.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Binding Sites
  • Bone and Bones / drug effects
  • Bone and Bones / metabolism
  • Chelating Agents / chemical synthesis*
  • Chelating Agents / chemistry
  • Chelating Agents / pharmacology*
  • Diphosphonates / chemical synthesis*
  • Diphosphonates / chemistry
  • Diphosphonates / pharmacology*
  • Kidney / drug effects
  • Kidney / metabolism
  • Ligands
  • Liver / drug effects
  • Liver / metabolism
  • Male
  • Molecular Structure
  • Rats
  • Rats, Sprague-Dawley
  • Small Molecule Libraries / chemical synthesis
  • Small Molecule Libraries / chemistry
  • Small Molecule Libraries / pharmacology
  • Stereoisomerism
  • Tissue Distribution / drug effects
  • Uranium / chemistry*
  • Uranium / pharmacokinetics*
  • Uranium / urine

Substances

  • Chelating Agents
  • Diphosphonates
  • Ligands
  • Small Molecule Libraries
  • Uranium